DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptid
DGCR8
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle DGCR8 Produkte
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-DGCR8 antibody (Catalog #: ARP40984_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Hintergrund
-
DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Alias Symbols: C22orf12, DGCRK6, Gy1, pasha
Protein Interaction Partner: RNASEN,RNASEN,RNASEN
Protein Size: 773 - Molekulargewicht
- 85 kDa
- Gen-ID
- 54487
- NCBI Accession
- NM_022720, NP_073557
- UniProt
- Q8WYQ5
-
Sie sind hier:
